Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01E
- Chemical subgroupL01EX
- Chemical substanceL01EX29Vimseltinib
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 3 registrations
Netherlands
CBG-MEB · 3 registrations
At a glance
- ATC code
- L01EX29
- Registers
- 5
- Registrations
- 9
- With their own page
- 9
- Companies
- 2
All medicines with Vimseltinib
Human medicines from every register that match Vimseltinib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
9 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Romvimza | United States | 14MG, 20MG, 30MG | capsule | Marketed | Deciphera Pharms |
| Romvimza | European Union | Authorised | Deciphera Pharmaceuticals (Netherlands) B.V. | ||
| Romvimza 14 MG Capsulas Duras | Spain | 14 mg | cápsula dura | Authorised | Deciphera Pharmaceuticals (Netherlands) B.V. |
| Romvimza 20 MG Capsulas Duras | Spain | 21,68 mg | cápsula dura | Authorised | Deciphera Pharmaceuticals (Netherlands) B.V. |
| Romvimza 30 MG Capsulas Duras | Spain | 30 mg | cápsula dura | Authorised | Deciphera Pharmaceuticals (Netherlands) B.V. |
| ROMVIMZA 14 mg harde capsules | Netherlands | Capsule, hard | Authorised | Deciphera Pharmaceuticals (Netherlands) B.V. | |
| ROMVIMZA 20 mg harde capsules | Netherlands | Capsule, hard | Authorised | Deciphera Pharmaceuticals (Netherlands) B.V. | |
| ROMVIMZA 30 mg harde capsules | Netherlands | Capsule, hard | Authorised | Deciphera Pharmaceuticals (Netherlands) B.V. | |
| Romvimza | Croatia | Authorised |